RE
Revelation Biosciences, Inc.
REVB · NASDAQ
$0.93 -4.90% (-$0.05)
1M -15.42%
Market Cap $3.64M
P/E Ratio -
Div. Yield -
ROE 100.20%
Bulios Fair Price
$0.77
17.2% downside
Trenutna cena
$0.93
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica REVB trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.36x
P/E N/A
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 103.44%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 104.28%
Asset turnover 0.00x
ROE 100.20%
Debt
100 /100
Low Debt/Equity 0.07x
Current ratio 6.21x
Int. coverage N/A
Stability
19 /100
Unstable Beta -0.17x
Profitable years 0
EPS volatility 594.17%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o REVB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James Rolke
Employees
8
Headquarters
San Diego
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report